Both in Biotechnology
Amgen vs Kymera Therapeutics
Over the past year AMGN returned +61.3% and KYMR returned +127.4%; their daily moves had a correlation of 0.16.
AMGN +61.3% KYMR +127.4%Growth of $1, one year, split-adjusted
| Metric | AMGN | KYMR |
|---|---|---|
| Price | $478.48 | $136.25 |
| Market cap | $258.68B | $11.63B |
| Today | +3.73% | +7.21% |
| 1 month | +18.8% | +28.6% |
| 6 months | +44.5% | +58.0% |
| Year to date | +46.2% | +75.1% |
| 1 year | +61.5% | +128.1% |
| Revenue growth (YoY) | +9.5% | −100.0% |
| Gross margin | 72.0% | — |
| Net margin | 23.6% | — |
| P/E (TTM) | 29.6× | — |
| Price / sales | 6.8× | 113.8× |
| Net cash | -$43.31B | $969.2M |
| Dividend yield | 2.11% | — |
| Volatility (60d) | 33.8% | 41.2% |
| Short % of float | 2.5% | 13.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).